Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market
The glucagon-like peptide-1 (GLP-1) obesity treatment market, long dominated by subcutaneous injections, is rapidly expanding into the realm of oral...
Search results for "U.S. Phase 3 clinical trial"
United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy
The race to develop regenerative cell therapies for an ultra-rare disease that leaves patients born without a thymus—making them highly vulnerable to...
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
FDA Grants Streamlined Path for MediPost’s Cartistem, Slashing U.S. Trial Burden
The U.S. Food and Drug Administration has agreed to a significantly streamlined clinical path for Cartistem, a landmark...
Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder
Patients suffering from light-chain amyloidosis, a rare and debilitating blood disorder that causes abnormal proteins...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs
A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
Fat accumulation in the liver can trigger severe inflammation even in individuals who completely abstain from alcohol.
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and...
Eli Lilly to Acquire GC Biopharma’s Curevo Vaccine in Blockbuster $1.5 Billion Deal
GC Biopharma’s U.S. affiliate, Curevo Vaccine, is set to be acquired by global pharmaceutical giant Eli Lilly in a deal...